A notorious predominantly English-speaking hacking group has launched a website to extort its victims, threatening to release about a billion records stolen from companies who store their customers' data in cloud databases hosted by Salesforce.
VEEV's Vault CRM is gaining traction with top biopharma firms like Merck, Gilead, and BMS, signaling its rise as the industry's commercial standard.
Salesforce, Inc. - Special Call Company Participants Emmanuel Schweitzer Presentation Emmanuel Schweitzer Good morning, everyone. This is Emmanuel.
Recently, Zacks.com users have been paying close attention to Salesforce.com (CRM). This makes it worthwhile to examine what the stock has in store.
Salesforce stock (NYSE: CRM) ought to be on your radar. Here's why – it is presently trading within the support range ($233 – $257), prices at which it has rebounded significantly in the past.
Salesforce upgraded to Buy as agentic AI adoption and Data Cloud growth signal long-term potential despite near-term monetization challenges. Q2 results showed revenue acceleration and strong EPS growth, but guidance for Q3 and FY2026 remains cautious, reflecting lingering demand concerns. CRM's forward P/E of 21.68 is significantly below the IT sector median, presenting an attractive entry point for patient investors.
Analysts' sentiment and downgrades can significantly impact a stock price, helping it to correct or even sustain downtrends despite otherwise bullish indications. The main point to remember is that downgrades and price target reductions are generally based on the overall market conditions.
Explore Salesforce.com's (CRM) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Salesforce, Inc. (NYSE:CRM ) Q2 Product & Innovation Overview Webinar Company Participants Michael Spencer - Executive Vice President of Investor Relations Madhav Thattai Raveendrnathan Loganathan Joseph Inzerillo Andy White Anna Le Presentation Michael Spencer Executive Vice President of Investor Relations Good morning. Thank you for joining us.
Guidewire is quietly bringing AI to an overlooked corner of the market: insurance providers.
Salesforce (CRM) shares tumbled Thursday after the cloud-based software company issued a sales forecast below Wall Street's expectations, raising concerns about demand for its flagship AI agent platform.
Despite posting favorable Q2 results after market hours on Wednesday, Salesforce (CRM) stock dropped as much as 12% in today's trading session.